4
Changes in Ownership
LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-22-007167
Chief Executive Officer gave up 48,053 shares (to pay taxes)
- Chief Executive Officer acquired 197,343 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
COATS LONNEL · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 1 in the form | +79,380 | 516,093 | D | ||
| 2022-02-28 | Exercise or conversion : show line 2 in the form | +84,630 | 600,723 | D | ||
| 2022-02-28 | Exercise or conversion : show line 3 in the form | +33,333 | 634,056 | D | ||
| 2022-02-28 | Shares withheld for taxes : show line 4 in the form | −48,053 | $2.85 | $136,951 | 586,003 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −79,380 | 0 | D |
| 2022-02-28 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −84,630 | 84,630 | D |
| 2022-02-28 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −33,333 | 66,667 | D |
Loading xslF345X03/form4.xml…